Search results for "intracranial hemorrhages"

showing 10 items of 26 documents

Does Endovascular Treatment with Curative Intention Have Benefits for Treating High-Grade Arteriovenous Malformation versus Radiosurgery? Efficacy, S…

2021

Background The treatment of high-grade arteriovenous malformations (AVMs) remains challenging. Microsurgery provides a rapid and complete occlusion compared with other options but is associated with undesirable morbidity and mortality. The aim of this study was to compare the occlusion rates, incidence of unfavorable outcomes, and cost-effectiveness of embolization and stereotactic radiosurgery (SRS) as a curative treatment for high-grade AVMs. Methods A retrospective series of 57 consecutive patients with high-grade AVM treated with embolization or SRS, with the aim of achieving complete occlusion, was analyzed. Demographic, clinical, and angioarchitectonic variables were collected. Both t…

AdultIntracranial Arteriovenous MalformationsMalemedicine.medical_specialtyAdolescentmedicine.medical_treatmentCost-Benefit AnalysisLower riskRadiosurgeryRadiosurgeryArteriovenous malformationEmbolization03 medical and health sciencesYoung Adult0302 clinical medicineSeizuresparasitic diseasesOcclusionSpetzler-Martin ScalemedicineHumansEmbolizationChildAgedCerebral Intraventricular HemorrhageAged 80 and overEndovascularbusiness.industryIncidence (epidemiology)Endovascular ProceduresArteriovenous malformationCost-effectiveness analysisMicrosurgeryMiddle Agedmedicine.diseaseSurgeryTreatment Outcome030220 oncology & carcinogenesisChild PreschoolStereotacticSurgeryFemaleNeurology (clinical)businessIntracranial Hemorrhages030217 neurology & neurosurgeryWorld neurosurgery
researchProduct

Increasing Burden of Stroke: The Dijon Stroke Registry (1987–2012)

2017

<b><i>Background:</i></b> We aimed to provide a representation of the global burden of stroke. <b><i>Methods:</i></b> All cases of stroke were prospectively identified through the population-based registry of Dijon, France (1987–2012). Attack rates and mortality rates (defined as stroke leading to death within 30 days) were standardized to the European standard. Sex differences and temporal trends were evaluated by calculating rate ratios (RRs). <b><i>Results:</i></b> In all, 5,285 stroke cases (52.7% women) were recorded. The standardized attack rate was 98.2/100,000/year and the mortality rate was 12/100,000/year, and…

AdultMalemedicine.medical_specialtyStroke registrySubarachnoid hemorrhageEpidemiologyAttack ratePopulation030204 cardiovascular system & hematologyBrain Ischemia03 medical and health sciencesSex Factors0302 clinical medicineRisk FactorsInternal medicineEpidemiologyPrevalenceHumansMedicineRegistrieseducationStrokeAgedAged 80 and overIntracerebral hemorrhageeducation.field_of_studybusiness.industryIncidenceMortality rateAge FactorsMiddle Agedmedicine.diseaseStrokeSurvival RateFemaleFranceNeurology (clinical)businessIntracranial Hemorrhages030217 neurology & neurosurgeryNeuroepidemiology
researchProduct

Intraparenchymal Brain Hemorrhage: "Birdlime" Effect Usefulness.

2018

The authors previously reported the novel transposition techniquefor microvascular decompression (MVD) using a tissue glue-coated collagen sponge (TachoSil Tissue Sealing Sheet; CSLBehring KK, Tokyo, Japan) soaked withfibrin glue (Tisseel 2-Component Fibrin Sealant, Vapor-Heated; Baxter Healthcare,Glendale, California, USA), termed the“birdlime”technique

Brain hemorrhagePathologymedicine.medical_specialtybusiness.industrySettore MED/27 - NeurochirurgiaAdhesiveBrainMicrovascular Decompression SurgeryText miningAdhesivesMedicineHumansSurgeryNeurology (clinical)businessIntracranial HemorrhagesIntracranial HemorrhageHumanCerebral HemorrhageWorld neurosurgery
researchProduct

Safety and Outcome of Revascularization Treatment in Patients With Acute Ischemic Stroke and COVID-19: The Global COVID-19 Stroke Registry.

2023

Background and ObjectivesCOVID-19–related inflammation, endothelial dysfunction, and coagulopathy may increase the bleeding risk and lower the efficacy of revascularization treatments in patients with acute ischemic stroke (AIS). We aimed to evaluate the safety and outcomes of revascularization treatments in patients with AIS and COVID-19.MethodsThis was a retrospective multicenter cohort study of consecutive patients with AIS receiving intravenous thrombolysis (IVT) and/or endovascular treatment (EVT) between March 2020 and June 2021 tested for severe acute respiratory syndrome coronavirus 2 infection. With a doubly robust model combining propensity score weighting and multivariate regress…

Fibrinolytic Agents/therapeutic useCerebral Hemorrhage/complicationsStroke/epidemiologyBrain Ischemia/complicationsTreatment OutcomeIschemic Stroke/epidemiologyCOVID-19/complicationsHumansCohort studiesEndovascular Procedures/adverse effectsRegistriesNeurology (clinical)610 Medicine & healthIntracranial Hemorrhages/etiologyThrombolytic Therapy/adverse effectsResearch Article
researchProduct

Recanalization Therapies in Acute Ischemic Stroke Patients Impact of Prior Treatment With Novel Oral Anticoagulants on Bleeding Complications and Out…

2015

Background— We explored the safety of intravenous thrombolysis (IVT) or intra-arterial treatment (IAT) in patients with ischemic stroke on non-vitamin K antagonist oral anticoagulants (NOACs, last intake <48 hours) in comparison with patients (1) taking vitamin K antagonists (VKAs) or (2) without previous anticoagulation (no-OAC). Methods and Results— This is a multicenter cohort pilot study. Primary outcome measures were (1) occurrence of intracranial hemorrhage (ICH) in 3 categories: any ICH (ICH any ), symptomatic ICH according to the criteria of the European Cooperative Acute Stroke Study II (ECASS-II) (sICH ECASS-II ) and the National Institute of Neurological Disorders and Stroke …

MaleBrain Ischemia/blood/drug therapyVitamin Kmedicine.medical_treatmentendovascular proceduresAnticoagulants/administration & dosage/adverse effects/classification/therapeutic useAdministration OralPilot ProjectsTissue plasminogen activatorBrain IschemiaCohort Studies2737 Physiology (medical)Atrial Fibrillation80 and overThrombolytic TherapyVitamin K/antagonists & inhibitorsStrokethrombolytic therapyAged 80 and overIncidenceAtrial fibrillationThrombolysisMiddle Aged3. Good healthvitamin K antagonistsTreatment OutcomeAdministrationAcute DiseaseCohortCerebral Hemorrhage/chemically induced/epidemiologyFemaleCardiology and Cardiovascular MedicineAtrial Fibrillation/complicationsmedicine.drugOralmedicine.medical_specialtyanticoagulantsnon-vitamin K antagonist oral anticoagulantsFactor Xa Inhibitors/administration & dosage/adverse effects/therapeutic useintracranial hemorrhagesintra-arterial treatment610 Medicine & healthAntithrombins2705 Cardiology and Cardiovascular MedicineDabigatranFibrinolytic AgentsPhysiology (medical)Internal medicinemedicineischemic strokeHumansAgedCerebral HemorrhageIntracerebral hemorrhageFibrinolytic Agents/therapeutic usebusiness.industryAntithrombins/administration & dosage/adverse effects/therapeutic usemedicine.diseaseddc:616.810040 Clinic for Neurologyanticoagulants; endovascular procedures; intra-arterial treatment; intracranial hemorrhages; ischemic stroke; non-vitamin K antagonist oral anticoagulants; thrombolytic therapy; vitamin K antagonistsPropensity score matchingbusinessFactor Xa InhibitorsCirculation
researchProduct

Global, regional, and national burden of stroke, 1990-2016

2019

Background: Stroke is a leading cause of mortality and disability worldwide and the economic costs of treatment and post-stroke care are substantial. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic, comparable method of quantifying health loss by disease, age, sex, year, and location to provide information to health systems and policy makers on more than 300 causes of disease and injury, including stroke. The results presented here are the estimates of burden due to overall stroke and ischaemic and haemorrhagic stroke from GBD 2016. Methods: We report estimates and corresponding uncertainty intervals (UIs), from 1990 to 2016, for incidence, preval…

MaleCost effectivenessIMPACTGlobal HealthGUIDELINES3124 Neurology and psychiatryBrain IschemiaGlobal Burden of DiseaseCOST-EFFECTIVENESS0302 clinical medicineRisk FactorsGlobal healthPrevalenceMedicine030212 general & internal medicineStrokePOPULATIONAged 80 and overRISKeducation.field_of_studyIncidence (epidemiology)Mortality rateIncidenceAge FactorsMiddle AgedPREVALENCEStrokeFemaleLife Sciences & BiomedicineIntracranial HemorrhagesAdultPopulationClinical Neurology03 medical and health sciencesHumanseducationAgedScience & TechnologyNeurology & Neurosurgerybusiness.industry3112 NeurosciencesKlinisk medicin1103 Clinical Sciencesmedicine.diseaseGBD 2016 Stroke CollaboratorsVerbal autopsyTRANSIENT ISCHEMIC ATTACKYears of potential life lostSocioeconomic FactorsHuman medicineNeurosciences & NeurologyNeurology (clinical)Clinical Medicine1109 NeurosciencesbusinessPRIMARY PREVENTION030217 neurology & neurosurgeryDemographyRCLancet Neurology
researchProduct

Endovascular Stroke Treatment and Risk of Intracranial Hemorrhage in Anticoagulated Patients

2020

Background and Purpose— We aimed to determine the safety and mortality after mechanical thrombectomy in patients taking vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs). Methods— In a multicenter observational cohort study, we used multiple logistic regression analysis to evaluate associations of symptomatic intracranial hemorrhage (sICH) with VKA or DOAC prescription before thrombectomy as compared with no anticoagulation. The primary outcomes were the rate of sICH and all-cause mortality at 90 days, incorporating sensitivity analysis regarding confirmed therapeutic anticoagulation. Additionally, we performed a systematic review and meta-analysis of literature on this to…

MaleMESH: RegistriesAdministration Oral030204 cardiovascular system & hematology0302 clinical medicineInterquartile rangeMESH: ThrombectomyRegistriesStrokeThrombectomyMESH: AgedMESH: Middle AgedMESH: Follow-Up StudiesMiddle Aged3. Good healthddc:StrokeMESH: Administration OralFemale[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Cardiology and Cardiovascular MedicineMESH: Intracranial HemorrhagesCohort studymedicine.medical_specialty610 Medicine & healthMESH: AnticoagulantsLower riskMESH: Stroke03 medical and health sciencesMeta-Analysis as TopicInternal medicinemedicineHumansMESH: Meta-Analysis as TopicMedical prescriptionAgedAdvanced and Specialized NursingMESH: Humansbusiness.industryAnticoagulantsOdds ratiomedicine.diseaseFactor Xa inhibitorsMESH: MaleStroke treatmentIntracranial hemorrhagesObservational studyNeurology (clinical)MESH: Systematic Reviews as TopicbusinessMESH: Female030217 neurology & neurosurgeryFollow-Up StudiesSystematic Reviews as Topic
researchProduct

Comparison of different quantification methods to determine hippocampal damage after cerebral ischemia

2014

Abstract Background Experimental stroke studies use multiple techniques to evaluate histopathological damage. Unfortunately, sensitivity and reproducibility of these techniques are poorly characterized despite pivotal influence on results. Method The present study compared several quantification methods to differentiate between two severities of global cerebral ischemia and reperfusion. Male Sprague-Dawley rats were randomized to moderate (10 min) or severe (14 min) ischemia by bilateral carotid occlusion (BCAO) with hemorrhagic hypotension. Neuronal cell count was determined in hippocampus at bregma −3.14 mm and −3.8 mm on day 3 and 28 post insult by counting neurons in the whole CA1 or in…

MalePathologymedicine.medical_specialtyTime FactorsIntracranial HypotensionIschemiaHippocampusCell CountNerve Tissue ProteinsBrain damageHippocampal formationSeverity of Illness IndexBrain IschemiaRats Sprague-DawleyBrain ischemiaRandom AllocationAnimalsMedicineColoring AgentsCA1 Region HippocampalStrokeFluorescent DyesNeuronsbiologyHistocytochemistrybusiness.industryGeneral NeuroscienceReproducibility of ResultsAntigens NuclearBregmaFluoresceinsmedicine.diseaseBenzoxazinesDisease Models Animalnervous systembiology.proteinmedicine.symptomNeuNbusinessIntracranial HemorrhagesJournal of Neuroscience Methods
researchProduct

Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015

2017

IMPORTANCE Elevated systolic blood (SBP) pressure is a leading global health risk. Quantifying the levels of SBP is important to guide prevention policies and interventions. OBJECTIVE To estimate the association between SBP of at least 110 to 115 mm Hg and SBP of 140 mm Hg or higher and the burden of different causes of death and disability by age and sex for 195 countries and territories, 1990-2015. DESIGN A comparative risk assessment of health loss related to SBP. Estimated distribution of SBP was based on 844 studies from 154 countries (published 1980-2015) of 8.69 million participants. Spatiotemporal Gaussian process regression was used to generate estimates of mean SBP and adjusted va…

MalePediatricsMyocardial IschemiaNormal DistributionPROGRESSIONBlood Pressure030204 cardiovascular system & hematologyGlobal Health0302 clinical medicineCause of DeathPrevalence030212 general & internal medicineStrokeCause of deathAged 80 and overMortality rateUncertaintyGeneral Medicine11 Medical And Health SciencesMiddle AgedStrokeCARDIOVASCULAR-DISEASEHypertensionCardiologyBlood pressureHipertensióFemaleQuality-Adjusted Life YearsARTERIAL STIFFNESSLife Sciences & BiomedicineIntracranial HemorrhagesMonte Carlo MethodAdultmedicine.medical_specialtySystolePressió sanguíniaRisk Assessment03 medical and health sciencesMedicine General & InternalAGEAge DistributionInternal medicineGeneral & Internal MedicinemedicineDisability-adjusted life yearHumansCORONARY-HEART-DISEASESystoleRenal Insufficiency ChronicSex DistributionMETAANALYSISAgedScience & Technologybusiness.industryMORTALITYKIDNEY-DISEASEmedicine.diseaseHealth SurveysQuality-adjusted life yearBlood pressureArterial stiffnessRISK-FACTORSbusiness
researchProduct

Stroke care organization overcomes the deleterious ‘weekend effect’ on 1-month stroke mortality: a population-based study

2013

Background and purpose Suffering a stroke during the weekend is associated with a poorer prognosis. The impact of implementing a dedicated stroke care network in Dijon, France, in 2003 on 30-day mortality in strokes/transient ischaemic attacks (TIA) occurring during weekends/bank holidays was evaluated. Methods All cases of stroke and TIA from 1985 to 2010 were identified from a population-based registry, using multiple overlapping sources of information. Demographics and clinical data were recorded. Cox regression models were used to evaluate associations between day of onset (weekdays versus weekends/bank holidays) and 30-day all-cause mortality. Data were stratified according to time per…

MalePediatricsmedicine.medical_specialtyWeekend effectPopulationPopulationTransient ischaemic attacksStroke careCommunity NetworksBrain Ischemiaparasitic diseasesHumansMedicinecardiovascular diseaseseducationStrokeAgedHolidaysAged 80 and overIntracerebral hemorrhageAnalysis of Varianceeducation.field_of_studybusiness.industryProportional hazards modelHazard ratioMiddle Agedmedicine.diseaseStrokeTreatment OutcomeNeurologyIschemic Attack TransientData Interpretation StatisticalEmergency medicineRegression AnalysisFemaleFranceNeurology (clinical)businessIntracranial Hemorrhageshuman activitiesEuropean Journal of Neurology
researchProduct